MedTrace Logo

Melanocytic Nevi in Children Under Chemotherapy

NCT00600431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2008-01-25

No results posted yet for this study

Summary

Changes in nevus count in 16 children (8m, 8f) aged between 2 and 17 years (median:8 years) suffering from different malignancies were examined every three months during a one-year period after starting chemotherapy. An age and sex matched control group underwent the same skin examinations.At the start of our study, the range of number of nevi in the chemotherapy group was 0-133, in the control group 2-199.

Conditions

  • Nevus, Pigmented

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Barbara Binder, MD · Department of Dermatology, Medical University of Graz, Austria

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00600431 on ClinicalTrials.gov